Tyra Biosciences, Inc. TYRA Return on invested capital

Return on invested capital at other companies

IncyteINCY

62.6%+24.7pp

BioMarin PharmaceuticalsBMRN

1.5%-9.2pp

ArriVent BioPharma, Inc.AVBP

-75.6%-28.0pp

Syndax PharmaceuticalsSNDX

-67.9%-12.9pp

Kura OncologyKURA

-149.3%-301pp

Bicara TherapeuticsBCAX

-100.6%—

FAQ

What is Tyra Biosciences, Inc.'s return on invested capital?

Tyra Biosciences, Inc. (TYRA) reported return on invested capital of -53.2% in Q1 2026.

How has Tyra Biosciences, Inc.'s return on invested capital changed year-over-year?

Tyra Biosciences, Inc.'s return on invested capital increased by 13.2% year-over-year, from -61.3% to -53.2%.

What is the long-term trend for Tyra Biosciences, Inc.'s return on invested capital?

Over 3 years (2022 to 2025), Tyra Biosciences, Inc.'s return on invested capital has grown at a -63.0% compound annual growth rate (CAGR), from -1,181.3% to -59.7%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.